Seroprevalence and social determinants of varicella in Turkey

Can Huseyin, Hekimoglu; Ozgen Alpay, Ozbek; Mestan, Emek; Mehmet Ali, Oktem; Galip, Kroglu; Mustafa, Sertel; Sevin, Ozdeniz; Ali, Ceylan; Ayla, Acikgz; Belgin, Unal

Can Huseyin, Hekimoglu; Ozgen Alpay, Ozbek; Mestan, Emek; Mehmet Ali, Oktem; Galip, Kroglu; Mustafa, Sertel; Sevin, Ozdeniz; Ali, Ceylan; Ayla, Acikgz; Belgin, Unal.

EMHJ-Eastern Mediterranean Health Journal. 2018; 24 (03): 295-301

in English | IMEMR | ID: emr-167933

ABSTRACT

ABSTRACT

Background:

In Turkey, varicella vaccine was introduced into routine childhood immunization in 2013, with a single dose administered to children aged 12 months. However, there is limited information on the morbidity [incidence and seroprevalence], mortality and burden of disease of varicella in the overall Turkish population.

Subject(s)

Humans; Male; Female; Child, Preschool; Child; Adolescent; Adult; Middle Aged; Aged; Aged, 80 and over; Seroepidemiologic Studies; Socioeconomic Factors; Chickenpox Vaccine; Cross-Sectional Studies; Chickenpox/diagnosis

Search on Google

XML

Index: IMEMR (Eastern Mediterranean) Main subject: Socioeconomic Factors / Seroepidemiologic Studies / Chickenpox / Cross-Sectional Studies / Chickenpox Vaccine Type of study: Prevalence study Limits: Adolescent / Adult / Aged / Child / Child, preschool / Female / Humans / Male Language: English Journal: East Mediterr Health J. Year: 2018

Similar

MEDLINE

LILACS

LIS

Search on Google

XML